During the past decade, Centrum Neurologii Krzysztof Selmaj conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centrum Neurologii Krzysztof Selmaj" are "Multiple Sclerosis" (6 trials), "Relapsing Multiple Sclerosis" (6 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Myasthenia Gravis" (1 trials). Many other conditions were trialed in "Centrum Neurologii Krzysztof Selmaj" in a lesser frequency.

Most popular intervention types in "Centrum Neurologii Krzysztof Selmaj" are "Drug" (17 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (8 trials), "Placebo" (5 trials), "Fenebrutinib" (3 trials), "Interferon beta-1a" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Neurologii Krzysztof Selmaj" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Neurologii Krzysztof Selmaj". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centrum Neurologii Krzysztof Selmaj, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Neurologii Krzysztof Selmaj, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".